New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
07:42 EDTCLDA
theflyonthewall.com: Clinical Data initiates Phase III Stedivaze trial
Clinical Data announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze for use as a pharmacologic stress agent in myocardial perfusion imaging, a method for detecting defects in the blood supply to the heart. The Phase III trial will also compare the tolerability of Stedivaze to adenosine, a standard pharmacologic stress agent used in MPI scans. :theflyonthewall.com



News For CLDA From The Last 14 Days
Check below for free stories on CLDA the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
07:21 EDTCLDA
theflyonthewall.com: Clinical Data reports Q3 EPS (63c) vs. consensus of (65c)
Reports Q3 revenue $3.7M vs. consensus $3.63M. :theflyonthewall.com